- 18:00 - 07/10/2026 to 19:00 - 07/10/2026
- Virtual event, United Kingdom
The Takeda Oncology medical department invites you to this interactive webinar, which will bring together expert faculty to explore current practice in the management of polycythemia vera (PV). Through case-based discussions, expert presentations, and audience engagement, the clinical importance of sustained hematocrit (HCT) control, the impact of symptom burden on patients' daily lives, and current approaches to treatment and disease management will be examined. C-ANPROM/GB/OG/1091 | VV-MEDMAT-141910 | September 2026
The College is delighted to have approved this external event for CPD credits.
If you have any questions regarding this event, please see host's information at the bottom of this page or via the Book Now button.
TOPICS COVERED
- Maintaining HCT control in PV
- Current management and treatment approaches for PV
- Patient-reported outcomes and goals for care for patients with PV.
C-ANPROM/GB/OG/1091 | VV-MEDMAT-141910
| September 2026
WHO SHOULD ATTEND?
Healthcare professionals with a clinical specialty in hematology and/or oncology only.
SPEAKERS
- Prof. Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, UK. Clinical Director and Professor of Myeloproliferative Neoplasms
- Prof. Florian Heidel, Hannover Medical School, Germany, Professor, Director, and Chair of Hematology
Takeda has organized and funded this non-promotional educational webinar. Intended for healthcare professionals with a clinical specialty in hematology and/or oncology only.
For more information, please contact: [email protected].
